PTZ-induced seizures inhibit adenosine deamination in adult zebrafish brain membranes  by Siebel, Anna Maria et al.
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a  b  s  t  r  a  c  t
Adenosine  exerts  neuromodulatory  functions  with  mostly  inhibitory  effects,  being  considered  an endoge-
nous anticonvulsant.  The  hydrolysis  of  ATP  by  ectonucleotidases  is an  important  source  of  adenosine,  and
adenosine  deaminase  (ADA)  contributes  to  the regulation  of this  nucleoside  concentration  through  its
deamination.  In  this  study,  we tested  the  effect  of  pentylenetetrazole  (PTZ)-induced  seizures  on  ectonu-
cleotidase  and ADA  activities  in adult  zebraﬁsh  brain.  Our  results  have demonstrated  that  PTZ  treatmentseywords:
denosine
denosine deaminase
ctonucleotidases
eizures
entylenetetrazole
did  not  alter  ectonucleotidase  and  ADA  activities  in  membranes  and  soluble  fraction,  respectively.  How-
ever,  ecto-ADA  activity  was signiﬁcantly  decreased  in  brain  membranes  of  animals  exposed  to  5  mM and
15 mM  PTZ  treatments  (22.4%  and  29.5%,  respectively)  when  compared  to the  control  group. Semiquanti-
tative  RT-PCR  analysis  did  not  show  signiﬁcant  changes  after  the  PTZ  exposure  on  ADA gene  expression.
The  decreased  adenosine  deamination  observed  in  this  study  suggests  a modulation  of  extracellular
adenosine  levels  during  PTZ-induced  seizures  in  zebraﬁsh.ebraﬁsh
. Introduction
Epilepsy is one of the most common neurological diseases
orldwide. This disorder is characterized by the occurrence of
pontaneous and recurrent seizures that occur due to abnormal
xcessive and synchronous electrical activity of neuronal networks
22,20]. Adenosine is an endogenous modulator of brain functions
hat exhibits potent inhibitory effects on neuronal activity and has
mportant anticonvulsant properties. These anticonvulsant proper-
ies are mediated mainly by A1 receptors activation, which reduces
he presynaptic neurotransmitter release and stabilizes the post-
ynaptic membrane potential [17,24]. Several studies have shown
hat this nucleoside is effective in suppressing the development
nd spread of seizures, in addition to preventing the epileptogene-
is [21]. Adenosine treatments reduced the seizure frequency and
revented the progression of kindling epileptogenesis in animal
odels of epilepsy [33,41].
Abbreviations: ADA, adenosine deaminase; NTPDase, nucleoside triphosphate
iphosphohydrolase; PTZ, pentylenetetrazole.
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After exerting its effects through speciﬁc receptors, ATP is
hydrolyzed by the cell-surface-located enzymes termed ectonu-
cleotidases. Tri- and diphosphonucleosides may be hydrolyzed
by ectonucleoside triphosphate diphosphohydrolase (E-NTPDase)
family members, whereas ecto-5′-nucleotidase hydrolyzes nucle-
oside monophosphates producing adenosine. Therefore, ectonu-
cleotidases control ATP, ADP, AMP, and adenosine levels [47].
Although extracellular ATP is excitatory and might inﬂuence
epileptogenesis, this nucleotide can be converted into adenosine,
which has inhibitory effects [30]. Consequently, the control of ATP
and adenosine levels through the pathway of ectonucleotidases
may  represent a key mechanism in the modulation of seizures and
epileptogenesis (for review see [15]).
ADA is present both intracellularly and extracellularly and cat-
alyzes the irreversible hydrolytic deamination of adenosine to
inosine and ammonia. This enzyme is widely distributed in tis-
sues and body ﬂuids and shows different members in animal cells
[23,35]. Rosemberg et al. reported ecto- and cytosolic-ADA activ-
ities in zebraﬁsh brain [38]. Moreover, the different ADA-related
Open access under the Elsevier OA license.gene expressions were identiﬁed in this teleost [37].
Several rodent protocols have reported the role of ectonucleoti-
dases and ADA pathway in epilepsy. Late and prolonged changes
in nucleotide hydrolysis were reported after status epilepticus
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nduced by pilocarpine and kainate as well as PTZ-kindling pro-
ocols [9,10].  Moreover, adult rats submitted to one single seizure
pisode early in life presented enhanced extracellular ATP hydrol-
sis in hippocampal synaptosomes [16]. The administration of ADA
ctivity inhibitors effectively reduced seizures in rodents [18,40].
oreover, the adenosine deamination was signiﬁcantly increased
n the brain tissue of PTZ-kindled mice [27,28]. Thus, the investi-
ation of the effects promoted by PTZ-induced seizures in distinct
nimal models may  straightforward the knowledge related to acute
eizure episodes and purinergic signaling.
The zebraﬁsh is a small freshwater teleost which has been
ecoming widely used as a model to study the basis of epilepsy.
ebraﬁsh larvae exposed to PTZ presented seizure behavioral
nd electrical discharges similar to those reported in rodent
odels. Also, these responses were suppressed by antiepilep-
ic drugs [3,5]. Adult zebraﬁsh exposed to the chemoconvulsant
rugs PTZ, caffeine, and picrotoxin showed seizure-like behav-
oral responses and elevated whole-body cortisol levels [44].
TZ-treated adult zebraﬁsh showed an impairment in the passive
voidance responses, which was suppressed by the treatment with
alproic acid [32]. Concerning the purinergic signaling, biochemical
nd molecular studies have already characterized NTPDase, ecto-
′-nucleotidase, and ADA in zebraﬁsh brain [36,39,37,38].  Despite
he importance of ectonucleotidases and ADA pathway in seizure
ccurrence has been already demonstrated in rodents, there is
o evidence about the role of these enzymes after seizures in
ebraﬁsh, a non-mammalian model widely used for the screening
f new pharmacological tools and therapies. Therefore, the aim of
his study was to verify whether acute PTZ-induced seizures alter
ctonucleotidases and ADA pathway in zebraﬁsh brain.
. Materials and methods
.1. Animals
Adult wild type zebraﬁsh (Danio rerio) of both sexes were obtained from a
ommercial supplier (Red Fish, RS, Brazil) and acclimated for 2 weeks before the
xperiments in a 50 L thermostated aquarium ﬁlled with unchlorinated water
onstantly aerated. Fish were kept at 26 ± 2 ◦C under a 14–10 h light/dark cycle
hotoperiod and fed three times daily with commercial ﬁsh ﬂake. The use and
aintenance of zebraﬁsh were according to the “Guide for the Care and Use of Labo-
atory Animals” published by the US National Institutes of Health. The protocol was
pproved by the Ethics Committee of Pontiﬁcal Catholic University of Rio Grande do
ul  (PUCRS) under the number 09/00117-CEUA.
.2. Materials
Trizma base, ammonium molybdate, polyvinyl alcohol, malachite green,
ucleotides, adenosine, EDTA, EGTA, sodium citrate, Coomassie blue G, bovine serum
lbumin, calcium chloride, and PTZ were purchased from Sigma (St. Louis, MO,  USA).
agnesium chloride, phenol, and sodium nitroprusside were purchased from Merck
Darmstadt, Germany). TRIzol, SuperScriptTM III First-Strand Synthesis SuperMix,
aq  Platinum, GelRed and Low DNA Mass Ladder were purchased from Invitrogen
Carlsbad, CA, USA). All other reagents used were from analytical grade.
.3. In vitro assays
For in vitro experiments, PTZ (diluted in water) at 2.5, 5, 7.5, 10, 12.5, and 15 mM
as  directly added to the reaction medium, pre-incubated for 10 min  with the brain
embranes (for NTPDase, ecto-5′-nucleotidase, and ecto-ADA assays) or soluble
raction (for intracellular ADA) and were maintained throughout the enzyme assays.
or  the control group, the enzyme assays were performed in PTZ absence. Brain
amples were obtained and the enzymes activities were tested as described for
n  vivo assays.
.4. PTZ model
To induce seizures, zebraﬁsh were individually exposed to 2.5, 5, and 15 mM
TZ in a 250 mL  beaker. PTZ treatments were chosen based on previous study with
ebraﬁsh [3].  The animals were submitted to the treatment for 20 min  and the
eizure-like behavior was  classiﬁed according each stage: stage I – increased swim-
ing activity (2.5 mM),  stage II – whirlpool swimming behavior (5 mM)  and stage III
clonus-like seizures followed by loss of posture (ﬁsh falls to one side and remains
mmobile for 1–3 s) (15 mM)  as previously reported for zebraﬁsh larvae [3,5] andulletin 86 (2011) 385– 389
adults [44]. Control group was maintained in a 250 mL  beaker with tank water for
the  same period and conditions as the PTZ-treated groups.
2.5.  Preparation of soluble and membrane fractions
Brain samples were obtained as described previously [36,39,38]. Each inde-
pendent experiment was performed using biological preparations consisted of a
“pool” of ﬁve brains. First, zebraﬁsh were cryoanaesthetized, euthanized, and brains
were removed by dissection [43]. Samples were then further homogenized in a
glass-Teﬂon homogenizer according to the protocol for each enzyme assay. For NTP-
Dase and ecto-5′-nucleotidase assays zebraﬁsh brains were homogenized in 60 vol.
(v/w) of chilled Tris–citrate buffer (50 mM Tris–citrate, 2 mM EDTA, 2 mM EGTA,
pH 7.4). For ADA experiments, brains were homogenized in 20 vol (v/w) of chilled
phosphate buffered saline (PBS), with 2 mM EDTA, 2 mM EGTA, pH 7.4. The brain
membranes were prepared as described previously [4].  In brief, the homogenates
were centrifuged at 800 × g for 10 min  and the supernatant fraction was subse-
quently centrifuged for 25 min at 40 000 × g. The resultant supernatant and the pellet
obtained corresponded to the soluble and membrane fractions, respectively. For sol-
uble ADA activity experiments, the supernatant was collected and kept on ice for
enzyme assays. The pellets of membrane preparations were frozen in liquid nitro-
gen, thawed, resuspended in the respective buffers and centrifuged for 20 min at
40  000 × g. This freeze–thaw–wash procedure was used to ensure the lysis of the
brain vesicles membranes. The ﬁnal pellets were resuspended and used for enzyme
assays. All samples were maintained at 2–4 ◦C throughout preparation.
2.6. Ectonucleotidase assays
NTPDase and 5′-nucleotidase assays were performed as described previously
[36,39].  Zebraﬁsh brain membranes (3 g protein for NTPDase and 5 g protein for
5′-nucleotidase) were added to the reaction mixture containing 50 mM Tris–HCl (pH
8.0) and 5 mM CaCl2 (for the NTPDase activity) or 50 mM Tris–HCl (pH 7.2) and 5 mM
MgCl2 (for the 5′-nucleotidase activity) at a total volume of 200 L. The samples
were preincubated for 10 min at 37◦C before starting the reaction by the addition
of substrate (ATP, ADP or AMP) to a ﬁnal concentration of 1 mM.  The reaction was
terminated after 30 min  with 200 L trichloroacetic acid at a ﬁnal concentration of
5%. The samples were chilled on ice for 10 min and 1 mL  of a colorimetric reagent
composed of 2.3% polyvinyl alcohol, 5.7% ammonium molybdate, and 0.08% mala-
chite green was  added in order to determine the inorganic phosphate released (Pi)
[12].  The quantiﬁcation of Pi released was determined spectrophotometrically at
630 nm and the speciﬁc activity was expressed as nmol of Pi min−1 mg−1 of protein.
In  order to correct non-enzymatic hydrolysis of the substrates, controls with the
addition of the enzyme preparation after the addition of trichloroacetic acid were
used. All enzyme assays were performed in ﬁve independent experiments carried
out in triplicate.
2.7. Adenosine deaminase assays
Ecto- and cytosolic-ADA activities were determined as described previously
[38].  The brain fractions (5–10 g protein) were added to the reaction mixture
containing 50 mM sodium phosphate buffer (pH 7.0) and 50 mM sodium acetate
buffer (pH 5.0) for soluble and membrane fractions, respectively, in a ﬁnal volume
of  200 L. The samples were preincubated for 10 min  at 37 ◦C and the reaction was
initiated by the addition of substrate (adenosine) to a ﬁnal concentration of 1.5 mM.
The reaction was stopped after 75 min (soluble fraction) and 120 min (membrane
fraction) by the addition of 500 L phenol-nitroprusside reagent (50.4 mg of phenol
and 0.4 mg of sodium nitroprusside/mL). ADA activity was determined spectropho-
tometrically by measuring the ammonia produced over a ﬁxed time using a Berthelot
reaction as previously reported [42]. In order to correct non-enzymatic hydrolysis
of the substrates controls with the addition of the enzyme preparation after mixing
with phenol-nitroprusside reagent were used. The reaction mixtures were imme-
diately mixed to 500 L of alkaline-hypochlorite reagent (sodium hypochlorite to
0.125% available chlorine, in 0.6 M NaOH) and vortexed. Samples were incubated at
37 ◦C for 15 min and the colorimetric assay was carried out at 635 nm.  Incubation
times and protein concentrations were chosen in order to ensure the linearity of the
reactions. The ADA activity was  expressed as nmol of NH3 min−1 mg−1 of protein.
All enzyme assays were performed in ﬁve independent experiments carried out in
triplicate.
2.8.  Protein determination
Protein was  measured by the Coomassie blue method [11] using bovine serum
albumin as a standard.
2.9. Reverse transcription-polymerase chain reaction (RT-PCR)The expression of ADA-related genes ada1, ada2.1, ada2.2,  and adal was  analyzed
by a semiquantitative reverse transcription polymerase chain reaction (RT-PCR)
assay. TRIzol® reagent (Invitrogen) was employed to isolate total zebraﬁsh brain
RNA in accordance with manufacturer instructions. The purity of the RNA was spec-
trophotometrically quantiﬁed by calculating the ratio between absorbance values
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Table 1
In vivo effect of PTZ treatments on ectonucleotidase activities in adult zebraﬁsh brain
membranes.
Group n ATP hydrolysis ADP hydrolysis AMP  hydrolysis
Control 5 475.9 ± 101.6 68.6 ± 13.4 12.83 ± 2.3
2.5 mM 5 421.3 ± 92.1 64 ± 8.5 11.14 ± 1.7
5  mM 5 419.2 ± 87.7 72.2 ± 14 12.20 ± 1.6
15 mM 5 488.5 ± 104.5 68.2 ± 11.7 13.07 ± 1.3
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Fig. 1. Effect of PTZ treatments (2.5, 5, and 15 mM)  on membrane-bound (A) and
soluble (B) ADA activity from zebraﬁsh brain. Bars represent the mean ± S.E.M.
The symbol (*) represents a signiﬁcant difference from control group (one-wayhe nucleotide hydrolysis was expressed as nmol Pi min−1 mg−1 protein.
ata are expressed as mean ± S.E.M.
t 260 and 280 nm.  Afterwards, all samples were adjusted to 160 ng/L and cDNA
pecies were synthesized with SuperScriptTM First-Strand Synthesis SuperMix Kit
Invitrogen, USA), following the supplier’s instructions. The ˇ-actin primers were
esigned as described previously [13]. Primer sequences of ADA-related genes were
esigned and PCR reactions were performed [37]. PCR products were separated on a
.0% agarose gel with GelRed 10× and visualized with ultraviolet light. The fragment
engths expected for the PCR reactions were conﬁrmed using Low DNA Mass Ladder
nd ˇ-actin was  determined as an internal standard. Band intensities were analyzed
y optical densitometry using the software Image J 1.37 for Windows after running
ll  PCR products in a single gel. All RT-PCR assays were carried out in three indepen-
ent experiments, each one performed using biological preparations consisted of a
pool” of three brains.
.10. Statistical analysis
The data are shown as mean ± S.E.M. of ﬁve (enzyme assays) and four (molec-
lar analysis) independent experiments. Data were analyzed by one-way ANOVA
ollowed by Duncan post-hoc test. P < 0.05 were considered as signiﬁcant.
. Results
The in vivo effect of PTZ (at 2.5, 5, and 15 mM)  was  tested on NTP-
ase, ecto-5′-nucleotidase, and ADA activities in adult zebraﬁsh
rain. The animals remained exposed to PTZ treatments for 20 min,
nough time for all animals reach stage I – increased swim-
ing activity (2.5 mM),  stage II – whirlpool swimming behavior
5 mM)  and stage III – clonus-like seizures followed by loss of
osture (15 mM). Our results have demonstrated that PTZ treat-
ent in all concentrations tested did not alter ATP (P = 0.319),
DP (P = 0.785), and AMP  (P = 0.293) hydrolysis in zebraﬁsh brain
embranes (Table 1). In contrast, PTZ inhibited ecto-ADA activity
22.4% and 29.5%, respectively; P < 0.05) at 5 mM (10.6 ± 2.1 nmol
f NH3 min−1 mg−1 of protein) and 15 mM (9.6 ± 0.8 nmol of
H3 min−1 mg−1 of protein) when compared to the control group
13.7 ± 1.8 nmol of NH3 min−1 mg−1 of protein) (Fig. 1A). However,
he soluble ADA activity was not altered by PTZ exposure (Fig. 1B).
In order to elucidate whether PTZ has any direct effect on these
nzymes that could inﬂuence the in vivo experiments, we also
ested the in vitro effect of PTZ (at 2.5, 5, 7.5, 10, 12.5, and 15 mM)
n NTPDase, ecto-5′-nucleotidase and ADA activities. No changes
ere observed in the enzyme activities in the presence of PTZ in all
oncentrations tested (data not shown). Semiquantitative RT-PCR
xperiments were performed to verify whether the PTZ treatments
ave altered the expression of ADA-related genes. The results
id not show signiﬁcant effects of the PTZ treatments on ada1
P = 0.363), ada2.1 (440 bp; P = 0.056), ada2.1 (554 bp; P = 0.056),
da2.2 (P = 0.225), and adal (P = 0.299) gene expression in zebraﬁsh
rain (Fig. 2).
. Discussion
The ﬁndings of the present study have demonstrated that ecto-
DA was altered in zebraﬁsh brain during PTZ exposure. Soluble
DA, NTPDase, and 5′-nucleotidase activities have not shown sig-
iﬁcant changes. The decreased ecto-ADA activity suggests the
xistence of a modulation of extracellular adenosine levels during
TZ-induced seizures. Besides the adenosine release, the hydrol-
sis of ATP by ectonucleotidases is another important source ofANOVA, followed by Duncan test as post hoc, P ≤ 0.05). The speciﬁc enzyme activity
is  reported as nmol of NH3 min−1 mg−1 of protein.
extracellular adenosine. This enzyme pathway includes the NTP-
Dase family, which promotes ATP and ADP hydrolysis, and 5′-
nucleotidase, which hydrolyzes AMP  to adenosine [47]. Therefore,
this enzyme cascade has a dual function, because it removes the
excitatory signaling molecule ATP and concomitantly generates the
nucleoside adenosine, which has important inhibitory effects [1].
Our study has shown that NTPDase and 5′-nucleotidase activ-
ities have not been altered during acute seizures induced by PTZ.
Previous studies have reported changes in ectonucleotidase activ-
ities only at late periods after chemically induced seizures in
rodents. Increased ATP hydrolysis in hippocampal synaptosomes
was reported in adult rats submitted to kainate-induced seizure in
neonatal period [16]. However, ATP hydrolysis was not signiﬁcantly
different 12 h after the seizure from kainate-treated group when
compared to control group [16]. In addition, after PTZ-kindling,
an increased ATP hydrolysis was reported in the rats that were
more resistant to seizure development [10]. However, after a sin-
gle convulsive PTZ injection in rats, no differences in ATP, ADP
and AMP  hydrolysis were observed on ectonucleotidase activities
from synaptosomal-enriched fractions [10]. Likewise, our results
demonstrate that there were no differences in ATP, ADP and AMP
hydrolysis immediately after a single PTZ exposure (for 20 min) in
zebraﬁsh. These ﬁndings corroborate the hypothesis that recurrent
seizures could lead to late and prolonged changes in ectonucleoti-
dase activities, as a consequence of an adaptive plasticity induced
by recurrent seizures. Additionally, our results demonstrated, for
the ﬁrst time, that ADA activity is altered during a single PTZ
exposure, suggesting that this enzyme activity might modulate
adenosine levels in early periods after a single seizure in zebraﬁsh.
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rain  (A) and the enzyme/ˇ-actin mRNA ratios obtained by optical densitometry an
ersus  ˇ-actin expression (mean ± S.E.M) of four independent replicate RT-PCR exp
Studies have been reporting that the extracellular adenosine
evels rise markedly during epileptic seizures. In rats, hippocampal
denosine levels increased following seizures produced by bicu-
ulline, kainate, and PTZ [6].  In humans with intractable complex
artial epilepsy, microdialysis measurements demonstrated that
eizures increase extracellular adenosine range and also that the
denosine levels remain elevated above basal values after seizure
pisodes [19]. These ﬁndings support the hypothesis that adeno-
ine has been implicated in the arrest of seizures and postictal
efractoriness [19,7].  As previously reported, besides the cell uptake
nd phosphorylation to AMP, extracellular adenosine concentra-
ions can be regulated through its deamination [31]. Studies have
uggested an important role of this mechanism during patho-
hysiological conditions [34], since the inhibition of adenosine
eamination has shown an effective anticonvulsant strategy in
iverse epilepsy models [18,40]. PTZ-kindling induced an increased
DA activity in mice brain tissue, effect that was suppressed by
alproic acid treatment [27,28].
In this study, we showed that PTZ treatments signiﬁcantly
ecreased ecto-ADA activity, whereas they did not change adeno-
ine deamination in soluble fraction. Previous studies have
eported that the regulation of adenosine levels in intracellular and
xtracellular fractions in the zebraﬁsh brain might be promoted
y distinct ADA members (ADA1, ADA2, and ADAL), which have
iverse gene expression patterns and activity properties [37,38]
nd might contribute for the regulation of adenosine levels in differ-
nt manners. Adenosine deamination has been attributed mainly to
DA1 activity, a typical cytosolic enzyme that also acts as an ecto-
DA, cleaving extracellular adenosine [23,45]. Together with ADA1,
he ADA2 enzyme also contributes to adenosine deamination. How-
ver, it seems to act speciﬁcally in the extracellular fraction [45,46].
eyond its enzymatic function, there is evidence that ecto-ADA is
ound with adenosine receptors, modulating their afﬁnity [14,25].
lthough the ADAL functionality still remains unclear, the presence
f ADAL mRNA transcripts in zebraﬁsh brain [37] might indicate
 possible role for this ADA member in this species. Considering
hat the inhibition of adenosine deamination caused by PTZ expo-
ure was observed exclusively for the ecto-ADA activity, our results
uggest that ADA-related members are differentially modulated by
TZ treatments.e ﬁgure shows ˇ-actin, ada1, adal, ada2.1,  and ada2.2 expression in adult zebraﬁsh
 (B). The results were expressed as optical densitometry of the ADA-related genes
nts.
A  previous study from our group has already reported the
expression proﬁle of ADA-related genes (ada1, ada2.1,  ada2.2,  and
adal) in zebraﬁsh brain [37]. Our RT-PCR results showed that
PTZ-induced seizures did not interfere in the expression of these
ADA-related genes. Hence, the decreased adenosine deamination
observed cannot be associated with alterations in the transcrip-
tional pattern of ADA family enzymes. Since no direct effect of PTZ
on the enzyme activities was shown by in vitro assays, as well as any
alterations in the transcriptional pattern of ADA-related genes were
observed, we  suggest that the modulation of ADA activities might
involve posttranslational events. Rosemberg et al. showed that the
ADA-related enzymes have putative regulatory sites for posttrans-
lational mechanisms, such as phosphoylation/desphosphorylation
[37]. Therefore, further studies are required to evaluate the role of
these mechanisms in the modulation of ADA activity of zebraﬁsh.
Furthermore, taking into consideration that the control of the
adenosinergic signaling can also be exerted by adenosine uptake via
bi-directional transporters and by adenosine kinase in mammals
[31,8], further studies are important to demonstrate the impact
of these mechanisms in the modulation of adenosine levels in
zebraﬁsh.Wong et al. showed that caffeine, a nonselective antago-
nist of adenosine receptors, was  able to induce robust seizure-like
behavior in adult zebraﬁsh [44]. This result is in agreement with our
hypothesis that adenosine signaling is related to epileptic seizures
in zebraﬁsh. Despite the extensive use of rodents, zebraﬁsh has
been being increasingly recognized as an important model organ-
ism to study the neurobiology of epilepsy [2,26].  Recent studies
have shown the antiepileptic effects of valproic acid in the adult
zebraﬁsh, which coincides with reduced hsp70 mRNA expression,
preventing learning impairment promoted by PTZ treatment [32].
Moreover, PTZ-induced seizures result in a massive reduction in
cell proliferation in wide-ranging areas of the zebraﬁsh develop-
ing brain [29]. Several behavioral, electrographic, molecular, and
endocrine responses to induced-seizures have been characterized
in this species [3,5,44] and these tools can also be a tempting strat-
egy for further studies related to epileptic seizures in zebraﬁsh.In summary, our ﬁndings showed that adenosine deaminase
activity is altered during PTZ-induced seizures, whereas ectonu-
cleotidases activities are not affected. These results suggest that,
such as in mammalian models, the enzyme pathway involved in the
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ontrol of adenosine levels may  participate in the mechanisms of
eizure induction and development in zebraﬁsh. Furthermore, our
ata contribute to elucidate the adenosine signaling modulation
uring acute seizure episodes in zebraﬁsh.
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